Janux Therapeutics, Inc. (JANX)

Janux Therapeutics Revenue

Janux Therapeutics had revenue of $10.00M in the quarter ending September 30, 2025, with 2,177.90% growth. This brings the company's revenue in the last twelve months to $10.00M, down -23.37% year-over-year. In the year 2024, Janux Therapeutics had annual revenue of $10.59M with 30.99% growth.

• Revenue (ttm): $10.00M
• Revenue Growth: -23.37%
• P/S Ratio: 100.12
• Revenue / Employee: $123,457
• Employees: 81
• Market Cap: 993.04M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.59M	2.51M	30.99%
Dec 31, 2023	8.08M	-529.00K	-6.14%
Dec 31, 2022	8.61M	4.98M	136.79%
Dec 31, 2021	3.64M	-	-
Dec 31, 2020	-	-	-